Skip to main content

GSA CAPITAL PARTNERS LLP

Position in ALDX — Aldeyra Therapeutics, Inc.

CIK 1362033 LONDON, X0

Position in ALDX

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$1,006,561
+$588,804 QoQ
Shares Held
472,564
+91.2% QoQ
Ownership
0.783%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#20
of 108 holders
Holding Since
Sep 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALDX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names. ALDX ranks #36 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ALDX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,006,561 472,564
2026-03-31 $417,757 247,194
2025-12-31 $502,030 96,917
2025-09-30 $640,306 122,664
2025-06-30 $280,723 73,296
2024-06-30 $53,026 16,020
2024-03-31 $82,564 25,249
2023-12-31 $592,358 168,763
2023-09-30 $101,963 15,264
2023-06-30 $668,741 79,707
2023-03-31 $922,933 92,944
2022-12-31 $996,727 143,208
2022-09-30 $554,548 103,848
2022-03-31 $266,406 59,934
2021-12-31 $504,456 126,114
2021-09-30 $906,763 103,276
2021-06-30 $259,105 22,869
2020-12-31 $419,969 61,220
2020-09-30 $188,977 25,503